Takeda Pharmaceutical Company Limited - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
TAK New York 2834 www.takeda.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Takeda Pharmaceutical Company Limited

Adlib Appoints Kristen Sauter as President & GM of Life Sciences to Accelerate Its Vertical AI Strategy - Jun 4th, 2026 6:00 am
Is Takeda Pharmaceutical Company Limited (TAK) Facing Major Legal Risk After U.S. Jury Rules on Generic Drug Delay? - Jun 2nd, 2026 7:56 am
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading - Jun 1st, 2026 8:40 am
2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC - May 31st, 2026 6:00 pm
2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer - May 31st, 2026 6:00 pm
Immune Thrombocytopenia Market Forecast Signals Steady Growth During the Forecast Period (2026-2036) Backed by Pipeline Advancements | DelveInsight - May 28th, 2026 8:01 am
Takeda Pharmaceutical (TSE:4502) Valuation Check As Short Term Weakness Meets Longer Term Returns - May 27th, 2026 9:12 am
Can Asceniv Help ADMA Navigate the Current IG Market Challenges? - May 26th, 2026 12:58 pm
Denali Stock Dips as Biogen-Partnered Parkinson's Disease Study Fails - May 22nd, 2026 10:14 am
Will the IG Market Challenges Affect ADMA Biologics Prospects in 2026? - May 22nd, 2026 10:13 am
KROS Turns to Next Wave of TGF-Beta Muscle Therapies - May 22nd, 2026 9:10 am
Should You Buy KROS After Q1 Miss and Takeda Deal Reset? - May 22nd, 2026 9:06 am
2026 ASCO Abstract Highlights: Innovent Biologics' IBI363 (PD-1/IL-2α-bias bispecific fusion protein) Demonstrates Robust Survival Benefits in Long-Term Follow-up of PoC Study in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer - May 21st, 2026 5:49 pm
Takeda faces $885m hit after landmark pay-for-delay lawsuit verdict - May 20th, 2026 5:15 am
Immunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing update - May 20th, 2026 4:43 am
245-year-old pharma giant cuts 4,500 jobs amid legal troubles - May 19th, 2026 8:17 pm
Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge? - May 19th, 2026 12:30 pm
Update: Takeda Pharmaceutical Found Liable in Constipation Drug Antitrust Case - May 19th, 2026 7:04 am
Takeda Pharmaceutical Reportedly Found Liable in Constipation Drug Antitrust Case - May 19th, 2026 3:13 am
Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion - May 18th, 2026 9:34 am